MedPath

RYFINTUM 20 (Rivaroxaban Film Coated Tablets Ph. Eur. 20mg)

Registration Number: MAL24056084AZ

Approved
Approval ID

27487fe5b45bf1f4

Registration Number

MAL24056084AZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (1)

28 TabletsAvailable
Package Size: 28 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

RIVAROXABANActive
Monograph: 利伐沙班

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RYFINTUM 20 (Rivaroxaban Film Coated Tablets Ph. Eur. 20mg) - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform